Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The ICPO Foundation is a German-based non-profit organization dedicated to expanding global access to Radiotheranostics and Radioligand Therapy (RLT). Founded in 2019, the foundation operates through a unique model that includes the ICPO Academy, which provides standardized certification for medical professionals, and a global network of collaborating clinical centers. ICPO focuses on establishing international best practices for the manufacturing and clinical application of radiopharmaceuticals in oncology. By fostering a community of experts and industry partners, the foundation aims to transition precision oncology from specialized research into mainstream clinical care. Their efforts primarily support the treatment of prostate cancer and neuroendocrine tumors through targeted molecular imaging and therapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on International Centers for Precision Oncology.